OPKO Health to Report Third Quarter 2025 Financial Results on October 29
OPKO Health (NASDAQ: OPK) will report operating and financial results for the three and nine months ended September 30, 2025 after U.S. market close on Wednesday, October 29, 2025.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
OPKO Health (NASDAQ: OPK) will report operating and financial results for the three and nine months ended September 30, 2025 after U.S. market close on Wednesday, October 29, 2025.
Senior management will give a business update and discuss results and financial guidance on a conference call and live audio webcast starting at 4:30 p.m. Eastern on October 29. OPKO encourages pre-registration to receive a unique PIN for immediate access; dial-in options are 833-630-0584 (U.S.) and 412-317-1815 (International). A telephone replay is available until November 5, 2025 (passcode 8678248), and a webcast replay will be posted about one hour after the live call.
Details
News Market Reaction – OPK
On Oct 23, the first trading day after this news, OPK closed 0.66% above the previous close.
Data tracked by StockTitan Argus for the Oct 23 session.
AI-generated analysis. How Rhea-AI works. Not financial advice.
MIAMI, Oct. 22, 2025 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) plans to report operating and financial results for the three and nine months ended September 30, 2025 after the close of the U.S. financial markets on Wednesday, October 29, 2025. OPKO’s senior management will provide a business update and discuss results as well as financial guidance during a conference call and live audio webcast on October 29th beginning at 4:30 p.m. Eastern time.
CONFERENCE CALL & WEBCAST INFORMATION
OPKO encourages participants to pre-register for the conference call using this link. Callers who pre-register will receive a unique PIN to gain immediate access to the call and bypass the live operator. Participants may register at any time, including up to and after the call start time. Those unable to pre-register may participate by dialing 833-630-0584 (U.S.) or 412-317-1815 (International). A webcast of the call can also be accessed at OPKO’s Investor Relations page and here.
A telephone replay will be available until November 5, 2025, by dialing 877-344-7529 (U.S.) or 412-317-0088 (International) and providing the passcode 8678248. A webcast replay will be available beginning approximately one hour after the completion of the live conference call here.
About OPKO Health
OPKO is a multinational biopharmaceutical and diagnostics company that seeks to establish industry-leading positions in large, rapidly growing markets by leveraging its discovery, development, and commercialization expertise and novel and proprietary technologies. For more information, visit www.opko.com.
Contacts:
Alliance Advisors IR
Yvonne Briggs, 310-691-7100
ybriggs@allianceadvisors.com
or
Bruce Voss, 310-691-7100
bvoss@allianceadvisors.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.